glutamic acid has been researched along with rosiglitazone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hurtado, O; Lizasoain, I; Lorenzo, P; Mallolas, J; Morales, JR; Moro, MA; Nombela, F; Pereira, MP; Romera, A; Romera, C; Serena, J; Vivancos, J | 1 |
Haq, W; Katti, SB; Raghubir, R; Raza, S; Samuel, SS; Verma, R | 1 |
Chang, YF; Chen, CM; Cherng, CH; Chuang, MY; Kuo, CY; Lin, BF; Wen, LL; Wong, CS; Wu, ZF | 1 |
Cheng, SJ; Hung, WC; Lee, WT; Min, MY; Wong, SB | 1 |
Jiao, Y; Ren, S; Tang, Z; Wang, L; Wu, G; Wu, J; Zhou, H | 1 |
Jiao, Y; Wu, G | 1 |
7 other study(ies) available for glutamic acid and rosiglitazone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Topics: Animals; Astrocytes; Benzamides; Blotting, Western; Brain; Cells, Cultured; Chromatography, High Pressure Liquid; Coculture Techniques; Excitatory Amino Acid Transporter 2; Gene Expression; Glutamic Acid; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Male; Neurons; PPAR gamma; Promoter Regions, Genetic; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2007 |
Anti-stroke profile of thiazolidin-4-one derivatives in focal cerebral ischemia model in rat.
Topics: Animals; Brain; Brain Ischemia; Excitatory Amino Acid Transporter 2; Glutamic Acid; Glutathione; Male; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2011 |
Rosiglitazone attenuates cerebral vasospasm and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage.
Topics: Animals; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glutamic Acid; Neuroprotective Agents; Random Allocation; Rats; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones; Vasospasm, Intracranial | 2014 |
Rosiglitazone Suppresses In Vitro Seizures in Hippocampal Slice by Inhibiting Presynaptic Glutamate Release in a Model of Temporal Lobe Epilepsy.
Topics: Action Potentials; Anilides; Animals; CA1 Region, Hippocampal; Culture Media; Epilepsy, Temporal Lobe; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Glutamic Acid; Magnesium; Microtomy; Models, Biological; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Seizures; Synaptic Transmission; Thiazolidinediones; Tissue Culture Techniques | 2015 |
Rosiglitazone Infusion Therapy Following Minimally Invasive Surgery for Intracranial Hemorrhage Evacuation Decreased Perihematomal Glutamate Content and Blood-Brain Barrier Permeability in Rabbits.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Disease Models, Animal; Glutamic Acid; Hypoglycemic Agents; Intracranial Hemorrhages; Male; Minimally Invasive Surgical Procedures; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones | 2018 |
Optimizing the Time Window of Minimally Invasive Stereotactic Surgery for Intracerebral Hemorrhage Evacuation Combined with Rosiglitazone Infusion Therapy in Rabbits.
Topics: Animals; Blood-Brain Barrier; Cerebral Hemorrhage; Disease Models, Animal; Glutamic Acid; Interleukin-1beta; Interleukin-6; Minimally Invasive Surgical Procedures; Nitric Oxide Synthase; PPAR gamma; Rabbits; RNA, Messenger; Rosiglitazone; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Water | 2022 |